- €1.28bn
- €1.60bn
- €586.46m
- 42
- 34
- 65
- 41
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 162 | 146 | 511 | 519 | 586 |
Cost of Revenue | |||||
Gross Profit | 20.1 | -91.2 | 80 | 49.9 | 65.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 159 | 289 | 473 | 528 | 572 |
Operating Profit | 2.6 | -143 | 37.4 | -8.46 | 14.1 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -2.44 | -157 | 23.7 | -18.3 | -16.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.5 | -164 | 18.5 | -23.5 | -20.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -4.5 | -164 | 18.5 | -23.5 | -20.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.5 | -164 | 18.5 | -23.5 | -20.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.025 | -0.92 | 0.104 | -0.132 | -0.1 |